2000. The first Santa Fe Bone Symposium was held on Saturday, August 5, 2000, at The Bishop’s Lodge in Santa Fe, New Mexico. The faculty consisted of John Bilezikian, MD; Mike Lewiecki, MD; Paul Miller, MD; and Nelson Watts, MD. There were 66 participants and 10 exhibitors. Presentations included “Monitoring of Treatment for the New Millennium” (Dr. Watts), “Progress and Controversy in Osteoporosis Reporting” (Dr. Miller), “Hot New Treatment Strategies for Osteoporosis” (Dr. Bilezikian), and “Blazing New Trails in the Management of Vertebral Fractures” (Dr. Lewiecki). There was a faculty debate on several controversial topics, with a special appearance by Leon Lenchick, MD. There were 30 registered for the ISCD bone densitometry course, which was limited to physicians only.
2001. The second Santa Fe Bone Symposium, held on August 4, 2001, was moved to the Eldorado Hotel, near the Santa Fe Plaza, to allow participants and guests easier access to Santa Fe activities. Guest faculty included Nelson Watts, MD, who spoke on combination therapy and gave an update on ISCD activities; Mike McClung, MD, talking on bisphosphonate therapy and controversies in bone densitometry; Mary Bouxsein, PhD, speaking on the biomechanics of fractures; and Jane Cauley, DrPH, who addressed the relationship between osteoporosis and other diseases. There were 131 registered participants and 15 exhibitors. Mike Maricic, MD, and Oscar Gluck, MD, participated on the expert panel for challenging case presentations. Most participants indicated that they plan on returning next year, and voted on the program evaluation form to expand the symposium to 1½ days. The ISCD bone densitometry course had 80 physicians and technologists registered.
2002. The Santa Fe Bone Symposium was expanded to 1½ days (9 hours CME credit) at the request of previous attendees. Faculty included Cliff Rosen, MD; Dennis Black, PhD; Mike Maricic, MD; Leon Lenchik, MD; Deborah Grady, MD, MPH; and Paul Miller, MD. Once again there were over 100 attendees and many exhibitors representing pharmaceutical companies, device manufacturers, and bone marker products. The ISCD bone densitometry course had about 80 attendees.
2003. The symposium faculty consisted of Larry Riggs, MD; David Dempster, PhD; Laura Bachrach, MD; and Ken Saag, MD; with Paul Miller, MD, as special guest moderator. Highlighted topics were bone quality, bone densitometry and management of low BMD in children, osteoporosis in men, anabolic and antiresorptive therapy, and estrogen therapy in the post-WHI era. There were 135 attendees, 20 exhibitors, many industry guests, and 76 students at the ISCD Bone Densitometry Course.
2004. Speakers were Larry Raisz, MD; Steve Cummings, MD; Bess Dawson-Hughes, MD; Steve Petak, MD; and Paul Miller, MD. Topics included pathogenesis of osteoporosis, lessons for clinical practice from large prospective clinical studies, medico-legal issues in the management of osteoporosis, nutritional aspects of bone health, secondary causes of osteoporosis, antiresorptive therapy, and anabolic therapy.
2005. Speakers for 2005 were Harry Genant, MD; Robert Lindsay, MD; David Kendler, MD; Sydney Bonnick, MD; Michael Maricic, MD; and Michael Lewiecki, MD. Presentations covered estrogen and skeletal health, evaluation of osteoporosis, vertebral fracture assessment, ISCD Official Positions, fracture risk reporting, PTH and bisphosphonate therapy for osteoporosis, imaging of bone microarchitecture, and more. The luncheon satellite symposium on adherence to therapy was very well attended.
2006. Felicia Cosman, MD; Nancy Lane, MD; Mike Kleerekoper, MD; Neil Binkley, MD; Paul Miller, MD; and Mike McClung, MD gave presentations at the 2006 symposium. Topics were diverse in nature, with state-of-the-art topics and updates on many clinically relevant issues. Enduring educational material with highlights of the Santa Fe Bone Symposium was published: Lewiecki EM. Proceedings of the Santa Fe Bone Symposium 2006. Women’s Health. 2006;2(6):825-828.
2007. Faculty were Cyrus Cooper, MA, DM; John Bilezikian, MD; Marc Hochberg, MD; Marjorey Luckey, MD; Paul Miller, MD; and Mike Lewiecki, MD. Topics included new agents in development for the treatment of osteoporosis, new paradigms fracture risk assessment, evaluation for secondary causes of osteoporosis, epidemiology of osteoporosis, nonvertebral fracture risk reduction, osteonecrosis of the jaw, new ISCD Official Positions for adults and children, and osteomalacia. There were several lively interactive sessions with extensive audience participation. For the first time, a sponsored scientific exhibit called “real life experience in osteoporosis” was held. Also for the first time, two meetings for endocrinology fellows were held in association with the Santa Fe Bone Symposium- a research symposium in metabolic bone disease and osteoporosis update, under the direction of Drs. Steve Harris and John Bilezikian. Enduring educational material in the form of a review authored by all speakers was published: Lewiecki EM, Bilezikian JP, Cooper C, Hochberg MC, Luckey MM, Maricic M, Miller PD. Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007. J Clin Densitom. 2008; 2008;11(2):313-324.
2008. Faculty was Richard Eastell, MD; John Bilezikian, MD; Paul Miller, MD; Sandy Baim, MD, Meryl LeBoff, MD. Scheduled presentation topics included an update on the development of new therapeutic agents for the treatment of osteoporosis; management of skeletal health with aromatase inhibitor therapy; combination therapy with anabolic and antiresorptive drugs; injectable bisphosphonate therapy; new guidelines for bone density testing; new guidelines for prevention and treatment of osteoporosis; skeletal health assessment with technologies other than central DXA; monitoring osteoporosis therapy; osteoporosis in men; clinical application of bone turnover markers; low BMD in premenopausal women; and more. Publication from the 2990 bone symposium: Lewiecki EM, Bilezikian JP, Cooper C, Hochberg MC, Luckey MM, Maricic M, Miller PD. Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007. J Clin Densitom. 2008;11(2):313-324.
2009. The 10th Anniversary Santa Fe Bone Symposium was conducted with the following faculty: Graham Russell, PhD, DM, FRS; John Bilezikian, MD; Michael Whyte, MD; Bob Recker, MD; Andy Laster, MD; Paul Miller, MD; Annette Torrez, RT, CDT; Dan Widholm, RT, CDT; and Isabel Torres, RT, CDT. Bob Marcus and Mike McClung were special guest expert panelists. Topics included the history and future of bisphosphonates; heritable disorders of RANKL/RANK/OPG signaling; bone histomorphometry for clinicians; new agents for the treatment of osteoporosis; overcoming regulatory and legislative hurdles in the care of osteoporosis; several panel discussions and interactive case presentations; oral presentations of abstracts by endocrinology fellows; and workshops on quality bone density testing. Enduring educational materials are in development.
Page Last updated: 09/01/09
